###begin article-title 0
ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity
###end article-title 0
###begin p 1
###xml 26 47 26 47 <email xmlns:xlink="http://www.w3.org/1999/xlink">joseph.craft@yale.edu</email>
CORRESPONDENCE Joe Craft: joseph.craft@yale.edu
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 46 48 46 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 284 287 284 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 281 287 281 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fas<sup>lpr</sup></italic>
###xml 292 295 292 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 292 295 292 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 322 325 322 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 322 325 322 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 343 347 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 423 424 423 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 752 754 752 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 771 774 771 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 771 774 771 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 926 928 926 928 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1232 1234 1232 1234 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 297 302 <span type="species:ncbi:10090">mouse</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
###xml 775 779 <span type="species:ncbi:10090">mice</span>
The role of specialized follicular helper T (TFH) cells in the germinal center has become well recognized, but it is less clear how effector T cells govern the extrafollicular response, the dominant pathway of high-affinity, isotype-switched autoantibody production in the MRL/MpJ-Faslpr (MRLlpr) mouse model of lupus. MRLlpr mice lacking the Icos gene have impaired extrafollicular differentiation of immunoglobulin (Ig) G+ plasma cells accompanied by defects in CXC chemokine receptor (CXCR) 4 expression, interleukin (IL) 21 secretion, and B cell helper function in CD4 T cells. These phenotypes reflect the selective loss of a population of T cells marked by down-regulation of P-selectin glycoprotein ligand 1 (PSGL-1; also known as CD162). PSGL-1lo T cells from MRLlpr mice express CXCR4, localize to extrafollicular sites, and uniquely mediate IgG production through IL-21 and CD40L. In other autoimmune strains, PSGL-1lo T cells are also abundant but may exhibit either a follicular or extrafollicular phenotype. Our findings define an anatomically distinct extrafollicular population of cells that regulates plasma cell differentiation in chronic autoimmunity, indicating that specialized humoral effector T cells akin to TFH cells can occur outside the follicle.
###end p 3
###begin p 4
###xml 216 219 212 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 229 232 225 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fas</italic>
###xml 232 235 228 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 432 434 414 416 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 97 104 <span type="species:ncbi:9031">chicken</span>
###xml 375 378 <span type="species:ncbi:10116">rat</span>
Abbreviations used: AFC, antibody-forming cell; AID, activation-induced cytidine deaminase; CGG, chicken gamma globulin; CSR, class switch recombination; GC, germinal center; ICOS, inducible T cell co-stimulator; MRLlpr, MRL/MpJ-Faslpr; NP, nitrophenyl; NZB/W F1, (NZB/BINJ x NZW/LacJ) F1; P-lig, P-selectin ligand; PSGL-1, P-selectin glycoprotein ligand 1; RIP-LTalphabeta, rat insulin promoter-driven lymphotoxin alpha and beta; TFH cell, follicular helper T.
###end p 4
###begin p 5
B.R. Marks and L.D. DiPlacido contributed equally to this paper.
###end p 5
###begin p 6
J.M. Odegard's present address is Dept. of Immunology, University of Washington, Seattle, WA 98195.
###end p 6
###begin p 7
C. Dong's present address is Dept. of Immunology, M.D. Anderson Cancer Center, Houston, TX 77030.
###end p 7
###begin p 8
###xml 317 318 317 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 658 659 658 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 771 772 771 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 958 959 958 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 793 797 <span type="species:ncbi:10090">mice</span>
CD4 T cells control several aspects of immune responses, and there is growing recognition that individual Th functions are mediated by distinct subsets. This paradigm is particularly clear for the peripheral tissue effector lineages Th1, Th2, and Th17, which each control a distinct class of innate immune mediators (1). These inflammatory effectors can be distinguished from T cells that perform the other essential and historically emblematic Th function, the regulation of antibody responses. However, our insight into the nature of such humoral effectors is relatively limited. The classical model that Th2 cells are responsible for antibody production (2) has been criticized for failing to account for the production of the Th1-associated isotypes IgG2a and IgG2b (3). Further, although mice that lack the IL-4R signaling molecule STAT6 have severe defects in peripheral Th2 responses, they produce normal levels of the IgG isotypes upon immunization (4), indicating that Th2 development is dispensable even for IgG1 production.
###end p 8
###begin p 9
###xml 392 393 392 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 568 569 568 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 571 572 571 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 788 789 788 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 1009 1010 1009 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 1012 1013 1012 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 1144 1146 1144 1146 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 1161 1163 1161 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 1164 1166 1164 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
More recently, consideration of the anatomy of antibody responses has provided insights into the specialized nature of B Th cells, although a comprehensive description of such CD4 Th subsets, which we refer to generally as humoral effectors, has yet to be achieved. The initial interactions between antigen-engaged CD4 T cells and B cells occur at the border of the T cell zone and follicle (5), and the early effects of Th cytokines can be observed there with the appearance of Ig heavy chain germline transcripts, the precursors to class switch recombination (CSR) (6, 7). Subsequently, subsets of B cells and Th cells migrate to the follicle and ultimately form the germinal center (GC), from which high-affinity, class-switched, and long-lived plasma cells and memory B cells emerge (5). Localization of T cells around the GC light zone as well as an ongoing CD40L requirement for affinity maturation in the GC indicate that selection of mutant B cells is a critical function of T cell help at that site (8, 9). More recent work has provided the significant insight that this T cell function is mediated by a distinct follicular helper T (TFH) cell subset (10-12).
###end p 9
###begin p 10
###xml 43 45 43 45 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 177 179 177 179 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 289 291 289 291 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 415 417 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 418 420 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 832 834 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 960 962 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 964 966 960 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 1107 1109 1103 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 1111 1113 1107 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 1115 1117 1111 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 1207 1209 1203 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 1211 1213 1207 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 1268 1270 1264 1266 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 61 66 <span type="species:ncbi:9606">human</span>
###xml 276 281 <span type="species:ncbi:10090">mouse</span>
###xml 585 589 <span type="species:ncbi:10090">mice</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
###xml 1139 1144 <span type="species:ncbi:9606">human</span>
Characterization of the follicle-resident TFH cell subset in human tonsil has been facilitated by the identification of the surface markers CXCR5 and CD57 (12). More recently, TFH cell differentiation has been achieved in vitro, allowing their further characterization in the mouse (13). TFH cells do not produce Th cytokines such as IFN-gamma, IL-4, or IL-17 but likely mediate their function via CD40L and IL-21 (10-16). Although multiple functions have been ascribed to IL-21 in vitro, data from in vivo experiments indicate that it is critical for IgG production. IL-21R-deficient mice have decreased IgG1, IgG2b, and IgG3 levels, and IL-21R/IL-4 double-knockout mice have defects in the production of all switched isotypes, including IgG2a, although neither cytokine is necessary for the production of this isotype on its own (17). In vitro, IL-21 promotes B cell apoptosis in the presence of anti-IgM, though death can be rescued by anti-CD40 signaling (18, 19). Exogenous IL-21 promotes CSR and IgG secretion in vivo and in vitro and is a potent inducer of B lymphocyte-induced maturation protein 1 (16, 17, 20), and the ability of human T cells to induce Ig secretion is largely dependent on IL-21 (16, 21). These data are consistent with a role for IL-21 in TFH cell-mediated centrocyte selection and differentiation into plasma cells. Still, it is not yet clear if IL-21 functions primarily within or outside the GC, or both.
###end p 10
###begin p 11
###xml 415 416 415 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
How Th cells promote antibody-forming cell (AFC) differentiation outside the follicle is poorly defined. In addition to seeding the GC, a subset of B cells at the interface of the T cell zone and follicle up-regulate CD138, migrate to the red pulp border, and form the extrafollicular focus. At this site, clumps of proliferative AFCs, or plasmablasts, undergo CSR and differentiation into long-lived plasma cells (6, 22, 23). Because T cell localization to the extrafollicular focus has not been reported, current models do not include a role for local T cell help in those responses (24). Instead, Th effects are thought to be exerted only before plasmablast migration from the T zone, though this idea has not been definitively demonstrated.
###end p 11
###begin p 12
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 534 537 534 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 531 537 531 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fas<sup>lpr</sup></italic>
###xml 542 545 542 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 542 545 542 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 575 578 575 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 575 578 575 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 590 591 590 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 757 759 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 863 865 863 865 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 942 944 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 990 993 990 993 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 990 993 990 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 1028 1030 1028 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 1032 1034 1032 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 1137 1140 1137 1140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 1137 1140 1137 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 1188 1190 1188 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 1250 1252 1250 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 1440 1443 1440 1443 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 1440 1443 1440 1443 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 1450 1452 1450 1452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 579 583 <span type="species:ncbi:10090">mice</span>
###xml 833 837 <span type="species:ncbi:10090">mice</span>
###xml 994 998 <span type="species:ncbi:10090">mice</span>
###xml 1141 1145 <span type="species:ncbi:10090">mice</span>
###xml 1444 1448 <span type="species:ncbi:10090">mice</span>
Clarifying the mechanics of the extrafollicular response is critical for understanding this important pathway for the production of autoantibodies. In normal mice, self-reactivity in B cells results in follicular exclusion and nonresponsiveness (25, 26), and provision of T cell help to such autoreactive cells leads to extrafollicular AFC differentiation rather than GC formation (27). A similar pattern of activation occurs spontaneously in some autoimmune strains (27, 28), the most well-characterized example being the MRL/MpJ-Faslpr (MRLlpr) model. In the spleens of MRLlpr mice, CXCR4+ plasmablasts form defined proliferative extrafollicular foci at the border of the T cell zone before migrating to the red pulp, in the absence of GC development (29-32). This pattern of activation is in stark contrast to autoimmune sanroque mice, in which self-reactive TFH cells promote spontaneous GC development resulting in lupus-like pathology (33). Although IgG autoantibody production in MRLlpr mice is clearly T cell dependent (34, 35), the details of this process are poorly defined. In addition to CSR, the extrafollicular focus of MRLlpr mice is also a site for somatic hypermutation (30), a process that, in mammals, is dependent on T cell help (36). Importantly, how T cells support this GC-like activity outside the follicle is unclear. Recently, IL-21 has been shown to play a role in IgG autoantibody production and pathology in MRLlpr mice (37), though the relevant source of this cytokine remains loosely defined.
###end p 12
###begin p 13
###xml 268 272 268 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 288 291 288 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 284 291 284 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos<sup>&#8722;/&#8722;</sup></italic>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 389 391 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 457 459 453 455 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 485 487 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 489 491 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 493 495 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">41</xref>
###xml 524 527 520 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 520 527 516 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos<sup>&#8722;/&#8722;</sup></italic>
###xml 598 600 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">42</xref>
To investigate the mechanisms of T cell help for the extrafollicular autoantibody response genetically, we took advantage of the well-recognized requirement for the molecule inducible T cell co-stimulator (ICOS) for Th cell differentiation and IgG antibody responses. Icos-deficient (Icos-/-) animals have marked defects in GCs (38) and CSR to both IFN-gamma- and IL-4-dependent isotypes (39). A primary reason for these defects is that the development of TFH cells is ICOS dependent (13, 40, 41). Importantly, however, Icos-/- animals also have defects in IgG production early after immunization (42), suggesting that ICOS also plays a role in the extrafollicular response.
###end p 13
###begin p 14
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 50 53 50 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 50 53 50 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 252 254 252 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 519 520 519 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 580 582 580 582 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 658 661 658 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 658 661 658 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 762 764 762 764 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
###xml 683 687 <span type="species:ncbi:10090">mice</span>
In this study, we find that Icos deficiency in MRLlpr mice causes an ontogenetic blockade of a population of effector T cells that down-regulate the surface glycoprotein P-selectin glycoprotein ligand 1 (PSGL-1). In addition to expressing CD40L, PSGL-1lo T cells are the sole producers of IL-21 and are uniquely able to induce IgG secretion in B cells in an IL-21- and CD40L-dependent manner. In their absence, plasmablast expression of activation-induced cytidine deaminase (AID) and extrafollicular development of IgG+ plasma cells are impaired. A substantial fraction of PSGL-1lo T cells express CXCR4 and localize to the extrafollicular sites in both MRLlpr and other autoimmune mice, and thus constitute a population of Th cells anatomically distinct from TFH cells.
###end p 14
###begin title 15
RESULTS
###end title 15
###begin title 16
ICOS co-stimulation promotes isotype switching in the extrafollicular response
###end title 16
###begin p 17
###xml 212 215 212 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 212 215 212 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 233 237 233 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 449 450 446 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 478 480 475 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R3</italic>
###xml 510 512 507 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 518 519 515 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 532 534 529 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R4</italic>
###xml 536 544 533 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 558 560 555 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R4</italic>
###xml 674 682 671 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 718 726 715 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 D</xref>
###xml 783 791 780 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 803 807 800 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 999 1014 996 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, B and D</xref>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
To assess the requirement for ICOS-dependent T cell help for the autoimmune extrafollicular response, we used intracellular staining to determine the number and isotype usage of plasma cells in the spleens of MRLlpr mice lacking the Icos gene. Spleen cells were stained for surface antigens and then fixed, permeabilized, and stained for both intracellular IgM and one of the four IgG isotypes. Plasma cells were identified by gating out TCRbeta/CD3+ and autofluorescent cells (R3), and then gating on the B220lo CD138+ population (R4; Fig. 1 A), and region R4 was analyzed for intracellular Ig expression. The percentage of plasma cells staining positive for each isotype (Fig. 1 B) as well as their absolute number (Fig. 1 D) are shown. Both groups had similar numbers of B cells (Fig. 1 C). Although Icos-deficient animals generated equivalent numbers of IgM-secreting cells as their age-matched controls, they failed to efficiently generate plasma cells expressing IgG1, IgG2a, IgG2b, and IgG3 (Fig. 1, B and D). These data were in close agreement with serum anti-double-stranded DNA antibody levels measured by isotype-specific ELISA (unpublished data), indicating that both Th1- and Th2-associated isotypes are ICOS dependent in this model.
###end p 17
###begin p 18
###xml 38 39 38 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 53 0 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ICOS is required for generation of IgG<sup>+</sup> plasma cells.</bold>
###xml 115 119 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 119 122 119 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 131 134 131 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 127 134 127 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos<sup>&#8722;/&#8722;</sup></italic>
###xml 138 141 138 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 138 141 138 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 151 152 151 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 232 234 232 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R4</italic>
###xml 290 292 290 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R3</italic>
###xml 337 339 337 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R4</italic>
###xml 495 496 493 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 501 502 499 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 526 527 524 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 782 786 776 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 786 789 780 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 790 794 <span type="species:ncbi:10090">mice</span>
ICOS is required for generation of IgG+ plasma cells. (A) Plasma cells were identified in the spleens of 23-wk-old Icos+/+ and Icos-/- MRLlpr animals (n = 3-5 for two experiments) by expression of CD138 and down-regulation of B220 (R4) after exclusion of T cells and autofluorescent cells (R3). (B) The percentage of plasma cells within R4 producing each antibody isotype are shown, as determined by intracellular Ig staining. Mean gate frequencies +/- SEM are shown. (C) Absolute number of CD90- CD19+ B cells in the spleen (n = 10-12). Horizontal bars indicate means. (D) Absolute numbers of plasma cells were calculated by multiplying the fraction of live single cells positive for each isotype by the total cell number. Data are expressed as means +/- SEM. *, P </= 0.05 versus Icos+/+ mice using the Mann-Whitney test.
###end p 18
###begin p 19
###xml 59 61 59 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 158 161 158 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 158 161 158 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 210 212 210 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 220 224 216 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">dull</sup>
###xml 476 484 468 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 560 563 552 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 560 563 552 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 570 578 562 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 588 589 580 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 597 599 585 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 679 683 667 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 813 815 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 817 819 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 1066 1068 1054 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">43</xref>
###xml 1099 1103 1087 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 1172 1187 1160 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, B and C</xref>
###xml 1221 1222 1209 1210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 329 336 <span type="species:ncbi:9031">chicken</span>
###xml 564 568 <span type="species:ncbi:10090">mice</span>
###xml 807 811 <span type="species:ncbi:10090">mice</span>
Previous work has established that GCs are ICOS dependent (38, 39). To confirm previous reports that spontaneous GC formation is minimal in the spleens of MRLlpr mice (29-32), we determined the frequency of GL7hi Igkappadull B cells, a surface phenotype that corresponds to normal GC B cells in the response to nitrophenyl (NP)- chicken gamma globulin (CGG; unpublished data). Although gut antigen-driven GC cells in Peyer's patches were abundant and robustly ICOS dependent (Fig. 2 A), as expected, we indeed observed very few GC B cells in the spleens of MRLlpr mice (Fig. 2 A). The GL7+ Igkappahi cells we observed and the few events falling in the GC gate are not reduced by Icos deficiency, and are unlikely to be true GC cells. In contrast, the spontaneous extrafollicular response is robust in these mice (30, 31). To address whether initiation of the extrafollicular response requires ICOS-dependent T cell help, we analyzed the kinetics of early plasmablast development by gating on CD19 and determining the percentage of B cells expressing CD44 and CD138 (43). To our surprise, B cells in Icos-deficient animals up-regulated CD44 and CD138 with normal kinetics (Fig. 2, B and C), indicating that the loss of IgG+ plasma cells is not caused by reduced plasmablast formation.
###end p 19
###begin p 20
###xml 0 87 0 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">AID expression in extrafollicular plasmablasts, but not their formation, requires ICOS.</bold>
###xml 109 111 109 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 119 121 115 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 198 202 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 202 205 198 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 214 217 210 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 210 217 206 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos<sup>&#8722;/&#8722;</sup></italic>
###xml 221 224 217 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 221 224 217 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 231 232 227 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 283 284 279 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 345 347 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">43</xref>
###xml 363 364 356 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 369 370 362 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 403 407 396 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 407 410 400 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 419 422 412 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 415 422 408 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos<sup>&#8722;/&#8722;</sup></italic>
###xml 429 430 422 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 483 484 476 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 489 490 482 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 563 564 556 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 658 662 651 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 662 665 655 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 674 677 667 670 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 670 677 663 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos<sup>&#8722;/&#8722;</sup></italic>
###xml 716 721 709 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aicda</italic>
###xml 909 913 898 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 913 916 902 905 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 942 943 931 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 225 229 <span type="species:ncbi:10090">mice</span>
###xml 423 427 <span type="species:ncbi:10090">mice</span>
###xml 678 682 <span type="species:ncbi:10090">mice</span>
###xml 787 791 <span type="species:ncbi:10090">mice</span>
###xml 917 921 <span type="species:ncbi:10090">mice</span>
AID expression in extrafollicular plasmablasts, but not their formation, requires ICOS. (A) Percentage of GL7hi Igkappalo GC B cells, gated on CD19, in the spleens (spl) and Peyer's patches (pp) of Icos+/+ and Icos-/- MRLlpr mice (n = 4-5 for two experiments). (B) Percentage of CD44+ cells bearing the early plasmablast marker CD138 (reference 43) in the TCRbeta- CD19+ B cell compartment of 18-wk-old Icos+/+ and Icos-/- mice (n = 4-6 for three experiments). (C) Percentage of CD90- CD19+ B cells expressing CD138 and high levels of CD44 at the indicated ages (n = 4-14 per age group; three pooled experiments are shown). (D) Plasmablasts were sorted from Icos+/+ and Icos-/- mice as gated in B, and expression of aicda mRNA encoding AID was determined by quantitative PCR (two pooled mice per experiment and two experimental replicates shown). All data are displayed as means +/- SEM. *, P </= 0.05 versus Icos+/+ mice using the Student's t test.
###end p 20
###begin p 21
###xml 93 94 93 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 315 320 315 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aicda</italic>
###xml 362 363 359 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 368 369 365 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 374 376 371 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 382 383 379 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 436 441 433 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aicda</italic>
###xml 445 449 442 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 449 452 446 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 636 639 609 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 632 639 605 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos<sup>&#8722;/&#8722;</sup></italic>
###xml 654 662 627 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 811 812 784 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 886 894 859 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 D</xref>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
The normal induction of plasmablasts in knockout animals indicated that ICOS must promote IgG+ plasma cell formation farther downstream in the extrafollicular response, possibly through induction of CSR. Because a limiting step in CSR is the expression of AID, we used quantitative PCR to measure the expression of aicda, the mRNA encoding AID, in sorted TCRbeta- CD19+ CD44hi CD138+ plasmablasts. We detected substantial expression of aicda in Icos+/+ plasmablasts (approximately40% of the level in GC cells from NP-CGG-immunized B6 mice; not depicted), and this expression level was strikingly reduced by approximately300-fold in Icos-/- plasmablasts (Fig. 2 D), indicating that ICOS is required for the induction of CSR in the extrafollicular pathway. Because we did not observe a concomitant increase in IgM+ plasma cells with the decrease in post-switch cells in knockout animals (Fig. 1 D), it is likely that ICOS is also involved in the proliferation and/or survival of the cells that do undergo CSR.
###end p 21
###begin title 22
ICOS is required for Th function and CXCR4 expression
###end title 22
###begin p 23
###xml 15 16 15 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 309 312 309 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 305 312 305 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos<sup>&#8722;/&#8722;</sup></italic>
###xml 363 364 363 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 372 373 369 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 377 378 374 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 383 385 380 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 391 392 388 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 539 543 536 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 543 546 540 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 585 588 582 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 585 588 582 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 698 706 695 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 772 776 769 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 883 891 880 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 1085 1093 1074 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 D</xref>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 436 440 <span type="species:ncbi:10090">mice</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
###xml 1136 1141 <span type="species:ncbi:10090">mouse</span>
The lack of IgG+ plasma cells in mice lacking a CD4 T cell co-stimulator indicated a T cell defect ipso facto, so we proceeded to analyze the production of cytokines involved in the provision of B cell help, including the induction of CSR. To avoid the confounding relative increase in naive cells in the Icos-/- CD4 compartment (unpublished data), we sorted B220- TCRbeta+ CD4+ CD44hi CD62L- effector T cells from knockout and control mice, cultured them with PMA and ionomycin for 24 h, and measured cytokine levels in the supernatants. Icos+/+ naive cells were sorted from young MRLlpr mice and stimulated as a negative control, and robust IL-2 production verified their viability and function (Fig. 3 A). Although IL-2 production by effector T cells was unaffected by Icos deletion, we observed a significant defect in the production of the B cell growth and switch factor IL-4 (Fig. 3 A). Production of other cytokines, including IFN-gamma, TNF-alpha, IL-5, and IL-10, was also substantially reduced (not depicted), reinforcing the view suggested by the plasma cell isotype data (Fig. 1 D) that ICOS does not promote Th skewing in mouse lupus but effector cytokine secretion in general.
###end p 23
###begin p 24
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos<sup>&#8722;/&#8722;</sup></italic>
###xml 0 116 0 116 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Icos<sup>&#8722;/&#8722;</sup></italic> effector T cells have defects in cytokine production, helper function, and CXCR4, but not CXCR5, expression.</bold>
###xml 135 136 132 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 140 141 137 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 146 147 143 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 152 154 149 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 160 162 157 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 185 189 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 189 192 186 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 201 204 198 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 197 204 194 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos<sup>&#8722;/&#8722;</sup></italic>
###xml 320 324 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 324 327 321 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 332 334 329 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 340 342 337 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 495 496 492 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 501 502 498 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 507 508 504 505 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 513 515 510 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 747 748 744 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 753 754 750 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 807 808 804 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1056 1060 1049 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 1060 1063 1053 1056 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1084 1085 1077 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 544 548 <span type="species:ncbi:10090">mice</span>
###xml 778 782 <span type="species:ncbi:10090">mice</span>
Icos-/- effector T cells have defects in cytokine production, helper function, and CXCR4, but not CXCR5, expression. (A) Sorted TCRbeta+ CD4+ B220- CD44hi CD62Llo effector T cells from Icos+/+ and Icos-/- mice were cultured with PMA and ionomycin for 24 h, and the indicated cytokines were measured in the supernatants. Icos+/+ CD44lo CD62Lhi naive T cells were stimulated as a control (representative of two experiments). (B) Effector CD4 cells were sorted as in A and cultured with sorted CD19+ B220+ CD90- CD44lo naive B cells from 8-wk-old mice in the presence or absence of anti-CD3 and anti-CD28. After 96 h, secreted IgG was measured in the culture supernatant (representative of three experiments). (C) Expression of CXCR4 and CXCR5 on CD4+ B220- T cells from 20-wk-old mice was determined by FACS (n = 3 for three experiments). The continuous line indicates specific staining, and the gray shading indicates isotype control. Values indicate the percent positive minus isotype control. All data are presented as means +/- SEM. *, P </= 0.05 versus Icos+/+ using the Student's t test.
###end p 24
###begin p 25
###xml 12 15 12 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 20 23 20 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 103 104 103 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 382 386 382 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 404 412 404 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 466 467 462 463 <sub xmlns:xlink="http://www.w3.org/1999/xlink">c</sub>
###xml 586 588 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">44</xref>
###xml 630 633 626 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 626 633 622 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos<sup>&#8722;/&#8722;</sup></italic>
###xml 706 708 702 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 797 798 793 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 803 805 799 801 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 810 812 806 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 841 844 837 840 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 841 844 837 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 945 948 941 944 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 941 948 937 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos<sup>&#8722;/&#8722;</sup></italic>
###xml 1078 1086 1074 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 24 28 <span type="species:ncbi:10090">mice</span>
###xml 845 849 <span type="species:ncbi:10090">mice</span>
Because IL-4-/-IL-13-/- mice are still capable of mounting an extrafollicular IgG1 response to NP-CGG (7), however, it seemed unlikely that the modest decrease in IL-4 production was solely responsible for the robust reduction in IgG1 AFCs that we observed. Another cytokine that can promote switching to IgG1 is IL-21 (17), and strikingly, the production of IL-21 was abolished in Icos-deficient cells (Fig. 3 A). IL-21 is a Th cytokine that signals through a gammac chain cytokine receptor family member, and its role in B cell plasmagenesis and class switching has recently emerged (44). To directly assess the capacity of Icos-/- CD4 T cells to induce B cell class switching in culture, we sorted CD62Llo effectors, as described in the previous paragraph, and co-cultured them with sorted CD19+ B220hi CD44lo naive B cells from young MRLlpr mice, with or without stimulation by anti-CD3 and anti-CD28 antibodies. Under these conditions, Icos-/- effectors were significantly less efficient at inducing B cell class switching as assessed by ELISA on the culture supernatants (Fig. 3 B), consistent with their impaired production of helper cytokines.
###end p 25
###begin p 26
###xml 21 24 21 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 17 24 17 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos<sup>&#8722;/&#8722;</sup></italic>
###xml 148 150 148 150 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 215 218 215 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 215 218 215 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 363 365 363 365 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 489 491 489 491 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 783 784 783 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 788 789 788 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 902 903 902 903 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 964 972 964 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 1071 1079 1071 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 1172 1174 1172 1174 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 1312 1314 1312 1314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 1348 1351 1348 1351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 1348 1351 1348 1351 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 1380 1381 1380 1381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1402 1408 1402 1408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 1436 1437 1436 1437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1451 1454 1451 1454 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1447 1454 1447 1454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos<sup>&#8722;/&#8722;</sup></italic>
###xml 1543 1545 1543 1545 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 1930 1932 1930 1932 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 219 223 <span type="species:ncbi:10090">mice</span>
###xml 1352 1356 <span type="species:ncbi:10090">mice</span>
###xml 1455 1459 <span type="species:ncbi:10090">mice</span>
The inability of Icos-/- effectors to secrete IL-21 and efficiently promote IgG secretion was reminiscent of the finding that ICOS is required for TFH cell development in normal mice (40). Because the spleens of MRLlpr mice are nearly devoid of GCs, however, the defect we observed in extrafollicular class switching was conceptually inconsistent with a loss of TFH cells. Therefore, we hypothesized that specialized humoral effector T cells may also act in the extrafollicular focus. As TFH cells express CXCR5 in similar fashion to follicular B cells, thus colocalizing to their site of interaction, we speculated that a population of Th cells might colocalize with extrafollicular plasmablasts through expression of CXCR4. Therefore, we analyzed CXCR4 and CXCR5 expression on B220- CD4+ splenocytes and found that, indeed, a substantial percentage of CD4 T cells expressed CXCR4. Further, this CXCR4+ population was absolutely dependent on ICOS co-stimulation (Fig. 3 C). Conversely, CXCR5 expression was not only ICOS-independent but in fact elevated in its absence (Fig. 3 C). To interpret these data, it is important to consider that CXCR5 is not only expressed on TFH cells but is up-regulated on almost all CD4 T cells shortly after activation, mediating their initial localization to the T/B interface (45). Because CXCR5 expression in MRLlpr mice occurs largely on CD62L+ effector cells (see Fig. 5), the accumulation of CXCR5+ cells in Icos-/- mice likely represents effector cells in an early state of differentiation rather than TFH cells. Thus, these data suggest that this early migration program is unimpaired in the absence of ICOS but that further differentiation along an extrafollicular pathway is arrested. In combination with the defect in helper function in vitro and reduction in AID expression in vivo, the loss of CXCR4 expression suggested strongly to us that ICOS is required for the development of a TFH cell-like CD4 effector subset that acts on plasmablasts.
###end p 26
###begin title 27
Extrafollicular helper cells can be identified by down-regulation of PSGL-1
###end title 27
###begin p 28
###xml 70 73 70 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 66 73 66 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos<sup>&#8722;/&#8722;</sup></italic>
###xml 308 309 308 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 316 317 316 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 377 378 377 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 384 386 384 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 822 830 822 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 882 884 882 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 894 896 894 896 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 905 913 905 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 926 928 926 928 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1107 1109 1107 1109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1111 1119 1111 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
A parallel approach that we used to assess Th cell development in Icos-/- mice was to stain for other surface markers associated with Th cells in antibody responses. In the ovalbumin response, effector cells have been separated according to CD62L expression and P-selectin binding such that P-selectin ligand+ (P-lig+) cells mediate delayed-type hypersensitivity, whereas P-lig- CD62Llo cells induce IgG1 (46). P-lig, which is detected using a P-selectin-Ig fusion protein, is generated by carbohydrate modification of PSGL-1, whereas unmodified PSGL-1 expression does not confer P-selectin binding. Because PSGL-1 has been reported to be constitutively expressed by T cells, we were surprised to find that among CD4 T cells that were negative for P-lig, a minor subset also down-regulated the PSGL-1 scaffold altogether (Fig. 4 A). Down-regulation of PSGL-1 was limited to the CD44hi and CD62Llo subset (Fig. 4 C). Thus, CD44hi antigen-experienced CD4 T cells can be subdivided into three surface phenotypes according to the expression of CD62L and PSGL-1. CD8 T cells, in contrast, remain uniformly PSGL-1hi (Fig. 4 B).
###end p 28
###begin p 29
###xml 0 120 0 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A novel population of CD4 T cells marked by PSGL-1 down-regulation requires both ICOS and B cells for their development.</bold>
###xml 129 130 129 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 138 139 135 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 143 144 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 168 171 165 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 168 171 165 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 276 277 270 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 282 283 276 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 325 326 319 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 509 510 503 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 515 516 509 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 530 534 524 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 534 537 528 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 546 549 540 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 542 549 536 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos<sup>&#8722;/&#8722;</sup></italic>
###xml 701 702 695 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 739 741 733 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 781 782 775 776 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 782 785 776 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 780 785 774 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">J<sub>H</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 789 792 783 786 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 789 792 783 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 829 830 823 824 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 830 833 824 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 828 833 822 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">J<sub>H</sub><sup>+/+</sup></italic>
###xml 844 845 838 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1030 1031 1020 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 550 554 <span type="species:ncbi:10090">mice</span>
###xml 793 797 <span type="species:ncbi:10090">mice</span>
A novel population of CD4 T cells marked by PSGL-1 down-regulation requires both ICOS and B cells for their development. (A) B220- TCRbeta+ CD4+ T cells from B6 and MRLlpr mice were stained with anti-PSGL-1 and a P-selectin-Ig fusion protein to detect P-lig. (B and C) TCRbeta+ B220- T cells were gated on CD4 or CD8, and CD4+ cells were separated according to CD44 expression, as indicated, and the expression of PSGL-1 and CD62L was determined on these populations. (D) Expression of PSGL-1 and CD62L on CD4+ B220- T cells from Icos+/+ and Icos-/- mice was determined by FACS. Percentages are shown. (E) The percentages of CD4 T cells that had down-regulated PSGL-1 at 9 and 16 wk of age are shown (n = 4-7). (F) The percentage of PSGL-1lo T cells in 25-wk-old B cell-deficient JH-/- MRLlpr mice was compared with age-matched JH+/+ controls (n = 3). A-D show representative data from a minimum of five animals. Data in E and F are expressed as means +/- SEM. *, P </= 0.05 compared with age-matched controls using the Student's t test.
###end p 29
###begin p 30
###xml 6 8 6 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 47 50 47 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 146 154 146 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 199 202 199 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 195 202 195 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos<sup>&#8722;/&#8722;</sup></italic>
###xml 266 268 266 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 276 291 276 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, D and E</xref>
###xml 336 344 336 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 386 388 386 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 432 435 432 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 432 435 432 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 478 479 478 479 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 479 482 479 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 477 482 477 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">J<sub>H</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 531 539 531 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 F</xref>
###xml 613 615 613 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 621 623 621 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 683 689 683 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 745 746 745 746 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 796 798 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 815 817 815 817 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 843 845 843 845 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 847 849 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 955 957 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">47</xref>
###xml 1124 1126 1124 1126 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 1142 1144 1142 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib48">48</xref>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 436 440 <span type="species:ncbi:10090">mice</span>
###xml 885 888 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 914 919 <span type="species:ncbi:9606">human</span>
###xml 998 1003 <span type="species:ncbi:10090">mouse</span>
PSGL-1lo CD4 cells increase in frequency in MRLlpr mice as disease progresses, reaching nearly 20% of the CD4 T cell compartment by 16 wk of age (Fig. 4 D). When we analyzed PSGL-1 expression on Icos-/- T cells, we found a marked reduction in the frequency of PSGL-1lo cells (Fig. 4, D and E) parallel to the loss of CXCR4 described in Fig. 3 C. Interestingly, the development of PSGL-1lo cells was also dependent on B cells, as MRLlpr mice bearing an Ig heavy chain deletion (JH-/-) have a significant reduction in their numbers (Fig. 4 F). Further, CXCR4 expression was almost exclusively confined to the PSGL-1lo CD62Llo population, and these cells expressed low levels of CXCR5 (Fig. 5). The expression of CXCR5 that we observed in the CD62L+ population is consistent with recent activation (45) rather than a TFH phenotype, which is CD62Llo (46). Although CXCR4, a coreceptor for HIV, is expressed broadly on human CD4 T cells, including GC T cells (47), it has not been well characterized in mouse T cells. Conditional deletion of CXCR4 in T cells does not affect GC formation, indicating that it is not critical for TFH cell function (48); the T cell-specific requirement for CXCR4 in the extrafollicular response was not addressed in that study.
###end p 30
###begin p 31
###xml 6 8 6 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 0 68 0 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PSGL-1<sup>lo</sup> T cells have an extrafollicular chemokine receptor profile.</bold>
###xml 202 204 202 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 281 289 281 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 291 292 291 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 653 654 649 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
PSGL-1lo T cells have an extrafollicular chemokine receptor profile. Expression levels of the chemokine receptors CXCR4, CXCR5, and CCR7 were compared between naive CD4 T cells and three subsets of CD44hi effector cells gated according to the expression of CD62L and PSGL-1, as in Fig. 4 C (n = 3 for three experiments). Specific staining is indicated by the solid line, and isotype control staining is indicated by the gray shading. For CXCR4 and CXCR5, values indicate the mean percent positive minus isotype control +/- SEM. For CCR7, values are the mean fluorescence intensity +/- SEM. *, P < 0.05 compared with all other groups using the Student's t test.
###end p 31
###begin p 32
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">49</xref>
###xml 353 355 353 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 381 383 381 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 418 424 418 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">50</xref>
###xml 598 600 598 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 833 835 833 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 864 870 864 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
Lymphocyte homing is not mediated solely by the acquisition of new chemokine receptors but also by modulation of expression or activity of competing receptors. Although nearly all CD4 T cells up-regulate CXCR5 after activation, CCR7 activity prevents the majority of these cells from localizing to the follicle (49). CCR7 levels were reduced on all CD44hi subsets, including PSGL-1lo cells, compared with naive cells (Fig. 5), though not to a striking extent. PSGL-1 itself has recently been implicated in binding and chemotaxis to CCR7 ligands (50). To evaluate the chemotactic responses of PSGL-1lo T cells to CCR7, CXCR5, and CXCR4 ligands, we performed transmigration assays in vitro. As expected, all effector T cell subsets were less responsive to the CCR7 ligands CCL19 and CCL21 than their naive counterparts, with the PSGL-1lo subset migrating the least (Fig. 6). Loss of PSGL-1 may therefore contribute to egress from the T cell zone.
###end p 32
###begin p 33
###xml 6 8 6 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 25 28 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 25 28 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 0 107 0 107 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PSGL-1<sup>lo</sup> T cells from MRL<italic><sup>lpr</sup></italic> mice have chemotactic properties consistent with extrafollicular localization.</bold>
###xml 389 391 387 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 398 400 396 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 427 428 425 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
PSGL-1lo T cells from MRLlpr mice have chemotactic properties consistent with extrafollicular localization. Migration of T cell subsets or control populations to the ligands for CCR7 (CCL19 and CCL21), CXCR5 (CXCL13), and CXCR4 (CXCL12) in a Transwell chemotaxis assay. Error bars indicate means +/- SEM, and results are representative of three experiments. *, P < 0.05 compared with CD62Llo PSGL-1hi cells using the Student's t test.
###end p 33
###begin p 34
###xml 120 122 120 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 167 173 167 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 206 208 206 208 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 276 278 276 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">51</xref>
###xml 614 616 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">52</xref>
###xml 709 710 709 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 766 768 766 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 778 784 778 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
Importantly, no responsiveness to the B cell zone chemokine CXCL13, which acts through CXCR5, was observed in the PSGL-1lo subset despite robust migration by B cells (Fig. 6), indicating that they are not TFH cells. We initially presumed that the expression of CXCR4 in PSGL-1lo T cells would confer an enhanced chemotactic response to its ligand, CXCL12, but the regulation of responses to this chemokine in vitro are more complex. Plasma cells, which migrate in a CXCR4-dependent manner to sites rich in CXCL12, rapidly lose responsiveness to this chemokine in vitro despite high expression of its receptor (51, 52). Consistent with these reports, we observed depressed in vitro migration to CXCL12 in CD138+ plasmablasts, and this reduction was mirrored in PSGL-1lo T cells (Fig. 6).
###end p 34
###begin p 35
###xml 67 69 67 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 322 330 322 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 B</xref>
###xml 568 576 568 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 A</xref>
###xml 672 674 672 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 685 687 685 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 773 775 773 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 855 857 855 857 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1003 1011 1003 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 G</xref>
###xml 1056 1058 1056 1058 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1126 1127 1126 1127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1265 1266 1265 1266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1289 1300 1289 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7, D&#8211;F</xref>
###xml 1504 1506 1501 1503 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1596 1598 1593 1595 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1600 1608 1597 1605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 H</xref>
Although these data were consistent with the localization of PSGL-1lo T cells to niches high in CXCL12, such as extrafollicular foci and the red pulp, we proceeded to directly assess their splenic localization using immunofluorescence microscopy. The T cell zone is clearly identified by colocalization of PSGL-1 and CD4 (Fig. 7 B). Extrafollicular foci are identifiable as dense clusters of plasmablasts at the border of the T cell zone and red pulp, with plasmablasts being distinguished from follicular B cells both by high levels of IgM staining and loss of B220 (Fig. 7 A). Using the image processing software ImageJ, we were able to enumerate the frequency of PSGL-1hi and PSGL-1lo T cells in the T cell zone, extrafollicular foci, and red pulp. In contrast to PSGL-1hi T cells, which were abundant in the T cell zone and rare at other sites, PSGL-1lo T cells were found at the greatest density in extrafollicular foci, though they also present to a lesser extent in the T cell zone and red pulp (Fig. 7 G). The extrafollicular localization of PSGL-1lo T cells was determined not only by their occurrence outside of B220+ follicles and CD4-dense T cell zones, but by their occurrence at the edge of the T cell zone and red pulp as defined by staining of F4/80+ red pulp macrophages (Fig. 7, D-F). Extrafollicular T cells lacking PSGL-1 were also readily identified using antibodies against TCRbeta (unpublished data). In contrast to the cells in the T cell zone, of which only a minority are PSGL-1lo, T cells found in extrafollicular foci and in the red pulp were almost exclusively PSGL-1lo (Fig. 7 H), confirming that extrafollicular localization is tightly associated with the loss of PSGL-1.
###end p 35
###begin p 36
###xml 6 8 6 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PSGL-1<sup>lo</sup> T cells localize to the extrafollicular focus.</bold>
###xml 552 553 552 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 792 793 791 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 947 948 946 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 940 945 <span type="species:ncbi:10090">mouse</span>
PSGL-1lo T cells localize to the extrafollicular focus. Four-color immunofluorescence microscopy was used to determine the expression of PSGL-1 on CD4 T cells in extrafollicular sites. For clarity, each panel displays two or three of the four channels. One field is represented in A-C, and another is represented in D-F. In all panels, red and blue signals indicate PSGL-1 and IgM staining, respectively. Green indicates B220 in A, F4/80 in D, and CD4 in B and E, and is left blank in C and F. White arrows highlight the location of extrafollicular CD4+ cells. Bar, 100 mum. (G and H) Enumeration of CD4 T cells expressing or lacking PSGL-1 in splenic T cell zones, extrafollicular sites, and the red pulp. The number of cells per millimeter squared in each site (G) and the percentage of CD4+ cells lacking PSGL-1 at each site (H) were determined from immunofluorescence micrographs. 100-300 cells, from multiple sections, were scored per mouse, n = 4. *, P < 0.05 compared with the T cell zone. EF, extrafollicular focus; RP, red pulp; TZ, T cell zone.
###end p 36
###begin title 37
###xml 6 8 6 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
PSGL-1lo cells are functionally specialized to drive IgG production
###end title 37
###begin p 38
###xml 103 104 103 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 111 113 111 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 345 347 345 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 362 364 362 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 566 568 562 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 621 629 617 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 A</xref>
###xml 724 726 720 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 747 749 743 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 760 762 756 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 775 783 771 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 B</xref>
###xml 943 945 939 941 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 953 961 949 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 A</xref>
Because we had described a defect in Th function in vitro and in vivo associated with the loss of CXCR4+ PSGL-1lo T cells in the setting of Icos deficiency, we wanted to directly address whether the loss of PSGL-1 identifies effector T cells with specialized B helper functions. To this end, we analyzed their cytokine production by sorting CD44lo naive and CD44hi effector cells, the latter separated further according to their expression of CD62L and PSGL-1. Consistent with the involvement of IL-4 and IFN-gamma in CSR, both of these cytokines were made by PSGL-1lo cells but were also made by other effector subsets (Fig. 8 A), as would be expected given their pleiotropic nature. Similarly, CD40L was expressed on CD62Llo cells of both PSGL-1hi and PSGL-1lo phenotypes (Fig. 8 B), consistent with the role of this effector molecule in both humoral and inflammatory responses. In striking contrast, IL-21 was secreted exclusively by PSGL-1lo cells (Fig. 8 A).
###end p 38
###begin p 39
###xml 6 8 6 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PSGL-1<sup>lo</sup> T cells are unique in their ability to promote IgG secretion via IL-21.</bold>
###xml 92 93 89 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 97 98 94 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 103 104 100 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 109 111 106 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 310 312 307 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 318 320 315 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 504 505 501 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 696 697 693 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 702 703 699 700 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 708 709 705 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 714 716 711 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1135 1137 1132 1134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1497 1498 1492 1493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
PSGL-1lo T cells are unique in their ability to promote IgG secretion via IL-21. (A) TCRbeta+ CD4+ B220- CD44hi effector cells were separated according to their expression of CD62L and PSGL-1 and were cultured with PMA and ionomycin for 24 h, and the indicated cytokines were measured in the supernatants. CD44lo CD62Lhi naive T cells were stimulated as a negative control. Results are representative of three experiments. (B) Percent expression of CD40L on the indicated subsets was determined by FACS (n = 3). Specific staining is indicated by a continuous line, and isotype control staining is indicated by gray shading. (C) Effector CD4 cells were sorted as in A and cultured with sorted CD19+ B220+ CD90- CD44lo naive B cells from young mice in the presence or absence of anti-CD3 and anti-CD28. After 96 h, secreted IgG was measured in the culture supernatant. B cell stimulation with an optimal dose of anti-CD40 with or without IL-4 is shown for comparison. Results are representative of three experiments. (D) IL-21 blocking antibody was added at fourfold increasing concentrations to a co-culture of naive B cells with PSGL-1lo effector cells. Isotype control antibody was added at maximum concentration. (E) CD40L blocking antibody MR1 or isotype control was added to similar co-cultures. D and E are representative of two experiments each. All data are shown as means +/- SEM. *, P < 0.05 compared with other effector subsets (A and C) or isotype control (D and E) using the Student's t test.
###end p 39
###begin p 40
###xml 64 66 64 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 80 81 80 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 114 117 114 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 110 117 110 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos<sup>&#8722;/&#8722;</sup></italic>
###xml 168 170 168 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 397 399 397 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 406 408 406 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 560 568 560 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 C</xref>
###xml 605 607 605 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 879 881 879 881 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 966 974 966 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 D</xref>
###xml 1163 1166 1163 1166 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 1163 1166 1163 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 1274 1276 1274 1276 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1316 1324 1316 1324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 E</xref>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
###xml 1167 1171 <span type="species:ncbi:10090">mice</span>
Given the corresponding defects in the differentiation of PSGL-1lo cells and IgG+ plasma cells we observed in Icos-/- mice, we proceeded to test directly whether PSGL-1lo cells were able to induce IgG class switching and secretion by co-culturing sorted naive B cells with anti-CD3/-CD28-stimulated sorted effector T cell subsets. Although other effector subsets had little effect, activated CD62Llo PSGL-1lo cells were sufficient to robustly induce isotype switching and secretion of IgG, to an even greater extent than an optimal dose of anti-CD40 and IL-4 (Fig. 8 C). Given the unique ability of PSGL-1lo cells to both make IL-21 and drive IgG secretion, as well as the emerging role for IL-21 in class switching and plasmagenesis, we hypothesized that IL-21 was important for their helper function. Indeed, the addition of IL-21 neutralizing antibody to co-cultures of PSGL-1lo cells and B cells significantly impaired IgG production in a dose-dependent manner (Fig. 8 D), confirming the important role for this cytokine in the collaboration of extrafollicular Th cells with B cells. Further, CD40L is known to play a critical role in T/B collaboration in MRLlpr mice, and as expected, the addition of CD40L blocking antibody MR1 completely ablated the ability of PSGL-1lo helper cells to induce IgG production (Fig. 8 E).
###end p 40
###begin title 41
Extrafollicular Th cells occur in other autoimmune models
###end title 41
###begin p 42
###xml 15 18 15 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 533 536 519 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 533 536 519 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 596 598 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 600 602 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib53">53</xref>
###xml 690 692 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib54">54</xref>
###xml 833 835 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib55">55</xref>
###xml 837 839 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib56">56</xref>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
###xml 339 342 <span type="species:ncbi:10116">rat</span>
###xml 412 427 <span type="species:ncbi:10090">transgenic mice</span>
###xml 513 517 <span type="species:ncbi:10090">mice</span>
###xml 537 541 <span type="species:ncbi:10090">mice</span>
###xml 711 715 <span type="species:ncbi:10090">mice</span>
Because the MRLlpr model is rather unique in the extent of the dominance of the extrafollicular pathway over the GC, it remained a possibility that the development of extrafollicular Th cells was limited to these mice. Thus, we analyzed two additional models: (NZB/BINJ x NZW/LacJ) F1 (NZB/W F1) spontaneously lupus-prone mice, as well as rat insulin promoter-driven lymphotoxin alpha and beta (RIP-Ltalphabeta) transgenic mice, a genetically and mechanistically unrelated model of chronic inflammation. NZB/W F1 mice differ from MRLlpr mice in that they develop robust spontaneous GCs with age (32, 53), though both follicular and extrafollicular activation pathways are likely operative (54). RIP-LTalphabeta mice express both LTalpha and LTbeta in the pancreas, kidneys, and skin, leading to massive infiltrates in these tissues (55, 56).
###end p 42
###begin p 43
###xml 119 121 112 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 135 143 128 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9 A</xref>
###xml 164 167 157 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 164 167 157 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 227 229 220 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 242 253 235 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9, B&#8211;D</xref>
###xml 271 273 264 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 341 342 327 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 344 346 330 332 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 364 375 350 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9, B&#8211;D</xref>
###xml 509 511 495 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 736 751 715 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9, E and F</xref>
###xml 785 788 764 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 785 788 764 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 935 937 914 916 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 997 999 976 978 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1029 1031 1008 1010 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 697 701 <span type="species:ncbi:10090">mice</span>
Analysis of the spleens of both NZB/W F1 and RIP-LTalphabeta mice revealed a striking age-dependent expansion of PSGL-1lo CD4 T cells (Fig. 9 A). Further, as in MRLlpr animals, CXCR4 was expressed specifically within the PSGL-1lo population (Fig. 9, B-D). However, PSGL-1lo cells from NZB/W F1 and RIP-LTalphabeta mice also contained a CXCR5+ TFH cell population (Fig. 9, B-D). These data suggested that Th cells with either a follicular or extrafollicular homing pattern could be identified within the PSGL-1lo subset of other autoimmune models. Confirming the extrafollicular homing pattern, Th cells were readily identified in the splenic extrafollicular foci of both NZB/W and RIP-LTalphabeta mice by immunofluorescence microscopy (Fig. 9, E and F; and not depicted). As in the MRLlpr strain, single-cell analysis of the immunofluorescence images indicated that T cells found in extrafollicular sites were almost exclusively PSGL-1lo, whereas those in the T cell zone were predominantly PSGL-1hi. Thus, Th cells with a PSGL-1lo phenotype occur at high frequency in multiple autoimmune models, a subset of which can be found in extrafollicular regions.
###end p 43
###begin p 44
###xml 6 8 6 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 0 66 0 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PSGL-1<sup>lo</sup> extrafollicular T cells occur in other autoimmune models.</bold>
###xml 93 95 93 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 102 104 102 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 331 333 324 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 440 442 426 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 490 492 476 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 498 500 484 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 561 564 547 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 561 564 547 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 666 672 645 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 853 855 832 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 893 894 872 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1073 1079 1045 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7</xref>
###xml 1144 1145 1116 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1231 1232 1203 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 402 406 <span type="species:ncbi:10090">mice</span>
###xml 1137 1142 <span type="species:ncbi:10090">mouse</span>
###xml 1152 1156 <span type="species:ncbi:10090">mice</span>
PSGL-1lo extrafollicular T cells occur in other autoimmune models. (A) The percentage of CD44hi PSGL-1lo cells within the CD4 T cell compartment of RIP-LTalphabeta and NZB/W F1 mice. 6-10 mice at varying ages were analyzed, and representative plots of the indicated ages are shown. (B and C) Expression of CXCR5 and CXCR4 on PSGL-1lo cells from 24-wk-old RIP-LTalphabeta (B) and 46-wk-old NZB/W F1 (C) mice. Continuous lines indicate PSGL-1lo effectors, gray-shaded histograms indicate CD44lo CD62Lhi naive CD4 T cells, and dotted lines indicate B cells. An MRLlpr control was stained concomitantly with the RIP-LTalphabeta group; profiles may also be compared with Fig. 5. Gate frequencies above background are shown. (D) Plots of CXCR5 and CXCR4 expression on effector subsets separated by CD62L and PSGL-1 expression. *, P < 0.05 compared with PSGL-1hi effector subsets using the Student's t test. (E and F) The number of cells per millimeter squared in each site in RIP-LTalphabeta (E) and NZB/W F1 (F) spleens were determined from immunofluorescence micrographs as in Fig. 7. 100-300 cells across multiple sections were counted per mouse (n = 4-6 mice per group). *, P < 0.05 compared with the T cell zone using the Student's t test. EF, extrafollicular focus; TZ, T cell zone.
###end p 44
###begin title 45
DISCUSSION
###end title 45
###begin p 46
###xml 90 93 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 90 93 90 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">42</xref>
###xml 623 624 623 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 630 631 630 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 644 645 644 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 737 740 737 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 726 740 726 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos ligand<sup>&#8722;/&#8722;</sup></italic>
###xml 94 99 <span type="species:ncbi:10090">mouse</span>
###xml 741 745 <span type="species:ncbi:10090">mice</span>
The extrafollicular response is the dominant pathway of autoantibody production in the MRLlpr mouse, and we find that ICOS functions in this pathway through the induction of a population of Th cells that traffics to extrafollicular focus. Although the contribution of ICOS to GC responses has received significant attention, its role in extrafollicular responses has been neglected despite an early report that IgG production the first week after immunization, largely derived from the extrafollicular response, is ICOS dependent (42). We have recapitulated these results in our own laboratory, where the percentage of CD19+ CD138+ surface IgG1+ plasmablasts 6 d after NP-CGG/alum immunization was substantially reduced in B6 Icos ligand-/- mice versus B6 controls (0.14 +/- 0.11% vs. 1.87 +/- 0.85%, respectively).
###end p 46
###begin p 47
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 337 340 337 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 337 340 337 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 374 376 374 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 622 624 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 881 882 881 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 941 944 941 944 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 951 954 951 954 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 977 979 977 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 993 994 993 994 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1119 1121 1119 1121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1138 1141 1138 1141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 1138 1141 1138 1141 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 1164 1166 1164 1166 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 1174 1176 1174 1176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 1177 1179 1177 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 1438 1440 1434 1436 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 341 345 <span type="species:ncbi:10090">mice</span>
###xml 971 975 <span type="species:ncbi:10090">mice</span>
###xml 1142 1146 <span type="species:ncbi:10090">mice</span>
###xml 1685 1690 <span type="species:ncbi:10090">mouse</span>
The ICOS-dependent Th cells that traffic to extrafollicular sites in MRLlpr mice were isolated and characterized based on their down-regulation of PSGL-1, though their essential features are expression of CXCR4, localization to the extrafollicular sites and B cell helper activity. Among the many effector cells that are generated in MRLlpr mice, the relatively small PSGL-1lo subset is remarkably unique in its ability to induce IgG secretion. One effector mechanism that is important for this function is the secretion of IL-21, an IL-2 family member previously shown to cooperate with IL-4 for IgG antibody production (17). IL-21 has been implicated in GC responses, and there is also data to suggest that it functions in the extrafollicular pathway. Although extrafollicular isotype switching to IgG1 in response to NP-CGG can occur even in the dual absence of IL-4 and IL-13 (7), this early IgG1 production is completely blocked in IL-4-/- IL-21R-/- double-knockout mice (17). Thus, CXCR4+ extrafollicular Th cells might be a source of IL-21 in the normal extrafollicular IgG1 response. Our observation that PSGL-1lo T cells from MRLlpr mice, in contrast to TFH cells (10-12), also secrete IL-4 and IFN-gamma raises the possibility that isotype instruction by these switch cytokines may continue in the extrafollicular focus. Clarification of this point will require both single-cell analysis of cytokine production within the PSGL-1lo subset and histological examination of the location of IL-21 production. The former experiment has been hampered by the lack of an intracellular staining reagent for IL-21, and both experiments may be precisely addressed with an IL-21 reporter mouse.
###end p 47
###begin p 48
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib57">57</xref>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">50</xref>
###xml 934 936 934 936 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 948 950 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib58">58</xref>
###xml 831 835 <span type="species:ncbi:10090">mice</span>
PSGL-1 has been sensibly thought to be constitutively expressed on T cells, because P-selectin binding is regulated not by PSGL-1 expression but by inducible glycosyltransferases that modify the PSGL-1 glycoform (57). We were surprised, therefore, to identify a population of activated CD4 T cells that had down-regulated the entire, presumably inactive, glycoprotein scaffold. Recently, however, PSGL-1 was also shown to participate in chemotactic responses to CCR7 ligands (50), providing a mechanistic reason why humoral effector T cells, which must leave the T cell zone to enter follicular or extrafollicular sites, down-regulate this molecule. Supporting a connection between PSGL-1 down-regulation and humoral effector function, CD4 T cells that are actively translating IL-4 protein in the lymph nodes of helminth-infected mice, as opposed to tissue-tropic effector cells requiring peripheral restimulation, also have a PSGL-1lo phenotype (58).
###end p 48
###begin p 49
###xml 10 13 10 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 10 13 10 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 91 93 91 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 195 197 195 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 476 478 469 471 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 510 512 503 505 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 763 765 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib59">59</xref>
###xml 238 253 <span type="species:ncbi:10090">transgenic mice</span>
In the MRLlpr autoantibody response, in which the extrafollicular pathway dominates, PSGL-1lo humoral effector T cells express CXCR4 and localize to the extrafollicular focus. In contrast, PSGL-1lo cells from NZB/W F1 and RIP-LTalphabeta transgenic mice, which develop both extrafollicular and GC responses, were found to have both CXCR4- and CXCR5-expressing cells. Indeed, the expression of CXCR5, like CXCR4, was largely restricted to this population, indicating that the TFH cell subset also bears a PSGL-1lo phenotype. The follicular versus extrafollicular trafficking pattern of Th cells may be instructed by their cognate B cells, the latter differentiating along the GC or plasmablast pathway, as determined by factors such as strength of the BCR signal (59).
###end p 49
###begin p 50
###xml 61 63 61 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 78 81 78 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 78 81 78 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 125 127 125 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 733 735 733 735 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 987 989 987 989 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 1051 1053 1051 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 1105 1107 1105 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib60">60</xref>
###xml 1123 1125 1123 1125 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 1132 1134 1132 1134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1151 1154 1151 1154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 1151 1154 1151 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 1155 1159 <span type="species:ncbi:10090">mice</span>
The effector mechanisms we defined for extrafollicular PSGL-1lo cells from MRLlpr mice, IL-21 and CD40L, are also shared by TFH cells (10, 14). These common features are not surprising given that T cell-dependent CSR and plasmagenesis occur in both GC B cells and plasmablasts, and both IL-21 and CD40L regulate these processes. It is possible that the more distinct features of follicular versus extrafollicular responses, however, such as long-lived plasma cell and memory formation, may in part reflect unique products of follicular versus extrafollicular helper cells that have yet to be defined. Alternatively, the helper cells that support extrafollicular responses may not be ontogenetically or mechanistically distinct from TFH cells but simply exhibit an alternative trafficking pattern. Illuminating the relationships between these humoral effector cells will be aided by global comparison of their effector genes and lineage specification factors. In microarray experiments, TFH cells have been shown to express B cell leukemia/lymphoma 6 (14), an essential transcription factor in GC B cells (60). Whether non-TFH PSGL-1lo T cells from MRLlpr mice also express this transcription factor is currently under investigation.
###end p 50
###begin p 51
###xml 29 31 29 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 295 298 295 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 291 298 291 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos<sup>&#8722;/&#8722;</sup></italic>
###xml 661 663 661 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 877 880 877 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 873 880 873 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos<sup>&#8722;/&#8722;</sup></italic>
###xml 1348 1350 1348 1350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
Based on our data that PSGL-1lo CD4 T cells are absent in both Icos mutant and B cell-deficient mice, we propose that the ICOS- B7-related protein 1 interaction during T/B collaboration provides one of the critical signals for the development of humoral effector cells. Our observation that Icos-/- effectors are still reasonably potent at providing B cell help in culture may be attributed to the minimal requirements, such as CD40L and IL-4, for IgG induction in vitro. An alternative, though not exclusive, explanation is that humoral effector T cells fail to migrate appropriately to sites of B cell differentiation in vivo. In this view, the lack of PSGL-1lo cells could reflect a failure of humoral effector cells to down-regulate PSGL-1, rather than fail to develop per se, an interpretation that would be consistent with the reduced CXCR4 expression we observed in Icos-/- effectors. The severe defect in IL-21 secretion, however, indicates a broader block in helper cell differentiation. Still, whether ICOS provides a specific differentiation signal or simply allows humoral effector cells to expand and survive is not clear. In addition, signaling to B cells through the ICOS ligand, B7-related protein 1, itself could potentially regulate plasma cell differentiation, complementing the activity of IL-21 and CD40L. To what extent PSGL-1lo T cell effects on plasmablasts, such as AID induction, occur within the extrafollicular focus itself versus earlier at the T/B interface remains undefined.
###end p 51
###begin p 52
###xml 134 136 134 136 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
###xml 577 579 577 579 <sub xmlns:xlink="http://www.w3.org/1999/xlink">FH</sub>
Functional characteristics such as cytokine production are commonly used to stratify effector CD4 T cells such as Th1, Th2, or Th17. TFH cells, in contrast, are defined essentially by their trafficking pattern, though with a view to their functional specialty. We have characterized a novel population of B Th cells that occur in chronic autoimmunity that do not conform to effector cell categories as currently defined. It remains to be clarified whether these extrafollicular Th cells merit designation as a subset distinct from their follicular counterparts, or rather are TFH cells that are recruited to an alternative site of B cell activation in an autoimmune setting.
###end p 52
###begin title 53
MATERIALS AND METHODS
###end title 53
###begin title 54
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 54
###begin p 55
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 3 6 3 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 179 181 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib55">55</xref>
###xml 488 492 481 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 539 541 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib61">61</xref>
###xml 574 577 567 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 574 577 567 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 634 637 627 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 634 637 627 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 642 645 635 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 638 645 631 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos<sup>&#8722;/&#8722;</sup></italic>
###xml 764 768 757 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmb1</italic>
###xml 785 789 778 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmb2</italic>
###xml 791 795 784 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmb3</italic>
###xml 801 805 794 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmb4</italic>
###xml 833 836 826 829 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 833 836 826 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 843 846 836 839 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 843 846 836 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 856 858 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib62">62</xref>
###xml 860 862 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib63">63</xref>
###xml 932 939 925 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D4Mit17</italic>
###xml 941 947 934 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D4Mit9</italic>
###xml 949 957 942 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D4Mit146</italic>
###xml 959 966 952 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D4Mit12</italic>
###xml 968 975 961 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D4Mit33</italic>
###xml 977 985 970 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D5Mit145</italic>
###xml 987 994 980 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D5Mit13</italic>
###xml 996 1004 989 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D5Mit356</italic>
###xml 1006 1013 999 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D5Mit24</italic>
###xml 1015 1022 1008 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D7Mit57</italic>
###xml 1024 1031 1017 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D7Mit82</italic>
###xml 1033 1041 1026 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D7Mit211</italic>
###xml 1043 1051 1036 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D7Mit147</italic>
###xml 1053 1060 1046 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D7Mit39</italic>
###xml 1062 1070 1055 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D10Mit51</italic>
###xml 1072 1080 1065 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D10Mit15</italic>
###xml 1082 1090 1075 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D10Mit11</italic>
###xml 1092 1101 1085 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D10Mit269</italic>
###xml 1103 1111 1096 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D17Mit16</italic>
###xml 1117 1120 1110 1113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tnf</italic>
###xml 1140 1143 1133 1136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1136 1143 1129 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos<sup>&#8722;/&#8722;</sup></italic>
###xml 1243 1247 1236 1240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmb1</italic>
###xml 1286 1289 1279 1282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr</sup>
###xml 1286 1289 1279 1282 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr</sup></italic>
###xml 1321 1325 1314 1318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmb1</italic>
###xml 1422 1424 1415 1417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib62">62</xref>
###xml 1427 1431 1420 1424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmb1</italic>
###xml 1643 1647 1636 1640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Icos</italic>
###xml 162 177 <span type="species:ncbi:10090">transgenic mice</span>
###xml 289 293 <span type="species:ncbi:10090">mice</span>
###xml 646 650 <span type="species:ncbi:10090">mice</span>
###xml 1290 1294 <span type="species:ncbi:10090">mice</span>
MRLlpr animals were obtained from the Jackson Laboratory and were maintained in specific pathogen-free conditions at the Yale School of Medicine. RIP-LTalphabeta transgenic mice (55) were provided by R. Mounzer and N. Ruddle (Yale School of Medicine, New Haven, CT). Spleens from NZB/W F1 mice were provided by A. Davidson (Feinstein Institute for Medical Research, Manhasset, NY). The Institutional Animal Care and Use Committee of Yale University approved all procedures. The disrupted Icos allele was generated as described previously (61), and was backcrossed to the MRLlpr background for six generations and intercrossed, and MRLlpr.Icos-/- mice were subsequently maintained as homozygotes. The MHC and four non-MHC autoimmune susceptibility loci (B6-derived Lmb1 and MRL-derived Lmb2, Lmb3, and Lmb4) are discernable in the MRLlpr and B6lpr genomes (62, 63). At the N6 generation, markers that define each of these intervals (D4Mit17, D4Mit9, D4Mit146, D4Mit12, D4Mit33, D5Mit145, D5Mit13, D5Mit356, D5Mit24, D7Mit57, D7Mit82, D7Mit211, D7Mit147, D7Mit39, D10Mit51, D10Mit15, D10Mit11, D10Mit269, D17Mit16, and Tnf) revealed that Icos-/- and control groups were fixed for the MRL genome at all intervals except the centromeric region of Lmb1 (Table S1, available at ). Because MRLlpr mice carrying the B6 allele of Lmb1 have slightly increased splenic lymphoproliferation, but autoantibody production is unaffected (62), Lmb1 has a minimal impact on the development of autoimmunity. Moreover, if anything, the B6 allele contributes to an increase in lymphocyte activation and so would not invalidate our conclusions; thus, the impact of Icos deficiency may actually be slightly stronger than we describe.
###end p 55
###begin p 56
In all experiments, precisely age- and sex-matched controls were included with experimental animals. In experiments with mixed-sex groups, both groups contained the same ratio of males and females.
###end p 56
###begin title 57
Flow cytometry.
###end title 57
###begin p 58
###xml 899 902 <span type="species:ncbi:10116">rat</span>
###xml 952 957 <span type="species:ncbi:10090">mouse</span>
###xml 1147 1152 <span type="species:ncbi:10090">mouse</span>
Spleens were extracted and homogenized by pressing through a 40-muM nylon filter. Red blood cells were lysed by hypotonic shock by brief exposure to distilled water followed by immediate isotonic restoration with 10x PBS. Surface staining was performed in ice-cold PBS with 1% FCS in the presence of FcR blocking antibody 2.4G2. For experiments involving chemokine receptor staining, antibody-labeled cells were placed at 37degreesC for 30 min, washed, and incubated with streptavidin-conjugated fluorophore on ice. With the exception of intracellular Ig staining, samples were analyzed unfixed, and dead cells were excluded based on staining with Hoechst 33342 (Sigma-Aldrich) added immediately before analysis. For intracellular Ig staining, cells were stained for surface antigens as described, fixed with a 1:4 dilution of Cytofix/Cytoperm (BD) in PBS for 20 min on ice, washed, blocked with 5% rat serum in Perm/Wash (BD), and incubated with anti-mouse Ig antibodies in Perm/Wash overnight at 4degreesC. In all experiments, cells were resuspended in PBS and analyzed on a four-laser flow cytometer (LSRII; BD). Antibody clones used were anti-mouse IgG1 (15H6; SouthernBiotech), IgG2a (R19-15; BD), IgG2b (R12-3; BD), IgG3 (R40-82; BD), IgM (gift of M. Shlomchik, Yale School of Medicine, New Haven, CT), TCRbeta (H57-587; BD), CD3 (145-2C11; BD), CD138 (281-2; BD), PSGL-1 (2PH-1; BD), B220 (RA3-6B2; BD), CD19 (1D3; BD), CD44 (IM7; eBioscience), CD62L (MEL-14; BD), CXCR4 (2B11; BD), CXCR5 (2G8; BD), and CCR7 (4B12; eBioscience). The fluorochromes used in each channel were FITC or AF488, PE, PE-Texas red, PE-Cy7, allophycocyanin (APC) or AF647, APC-Cy7 or APC-AF750, Hoechst 33342, and Pacific blue.
###end p 58
###begin title 59
Quantitative PCR.
###end title 59
###begin p 60
###xml 42 43 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 48 49 45 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 54 56 51 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 62 63 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 437 442 433 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aicda</italic>
###xml 522 527 518 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">actin</italic>
###xml 679 684 675 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aicda</italic>
###xml 808 813 804 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aicda</italic>
###xml 913 918 909 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">actin</italic>
Total RNA was isolated from sorted TCRbeta- CD19+ CD44hi CD138+ plasmablasts using the RNeasy Mini kit (QIAGEN) and treated with amplification grade DNase I (Invitrogen). 0.5 mug RNA was reversed transcribed with Superscript III (Invitrogen) using random hexamers, and the cDNA was subjected to real-time PCR using Taqman probes, HotStart Taq DNA polymerase (QIAGEN), and a thermocycler (3000XP; Stratagene). 10-fold serial dilutions of aicda (gift of V. Odegard and D. Schatz, Yale School of Medicine, New Haven, CT) and actin standard were included to generate standard curves. Starting cDNA quantity was calculated from ct values relative to the standard curve. The amount of aicda was normalized to the amount of actin in each sample. Forward primer, reverse primer, and probe sequences were as follows: aicda, 5'-CGGCTAACCAGACAACTTCG-3', 5'-GCATCTCGCAAGTCATCGA-3', and FAM-CGCATCCTTTTGCCCTTGTACGA-TAMRA; and actin, 5'-AGAGGGAAATCGTGCGTGAC-3', 5'-CAATAGTGATGACCTGGCCGT-3', and FAM-CACTGCCGCATCCTCTTCCTCCC-TAMRA.
###end p 60
###begin title 61
Cytokine measurements.
###end title 61
###begin p 62
###xml 247 252 <span type="species:ncbi:10090">mouse</span>
###xml 395 400 <span type="species:ncbi:10090">mouse</span>
###xml 501 506 <span type="species:ncbi:10090">mouse</span>
###xml 550 561 <span type="species:ncbi:3704">horseradish</span>
Effector T cells were sorted as indicated in the figures and cultured with 50 ng/ml PMA and 1 muM ionomycin for 24 h in complete Click's media. IFN-gamma, IL-4, IL-2, and IL-17 from culture supernatants were measured by a Luminex assay using anti-mouse cytokine beads (Beadlyte; Millipore). IL-21 was detected by sandwich ELISA as follows: Immulon-4 HBX (Millipore) plates were coated with anti-mouse IL-21 (R&D Systems), and bound IL-21 from culture supernatants was detected using biotinylated anti-mouse IL-21 (R&D Systems) followed by Extravidin-horseradish peroxidase (Sigma-Aldrich). Before analysis, supernatants were concentrated ninefold in 5-kD-cutoff Amicon Ultra-4 columns (Millipore).
###end p 62
###begin title 63
Chemotaxis assay.
###end title 63
###begin p 64
###xml 96 97 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 289 290 280 281 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Splenocytes were isolated in prewarmed serum-free RPMI 1640 with 0.5% BSA and 2 mM HEPES, and 106 cells in 100 mul were added to the upper chamber of 5-muM Transwell plates (Millipore) containing 500 mul of media in the lower chamber. Cells were preincubated for 1 h at 37degreesC in 5% CO2, and chemokines were added in 100 mul to the lower chamber and cells were allowed to migrate for 2 h. The percent migration was calculated by dividing the number recovered in the lower chamber by the number of input for each population. Specific migration was determined by subtracting the percent migrated without chemokine. Samples were run in duplicate at three chemokine dilutions. Results from the optimal chemokine concentration are shown in the figures and were as follows: 25 ng/ml CCL19, 100 ng/ml CCL21, 250 ng/ml CXCL12, and 3 mug/ml CXCL13.
###end p 64
###begin title 65
B cell help assay.
###end title 65
###begin p 66
###xml 4 6 4 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 71 72 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 122 123 122 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
CD44lo B220+ CD19+ naive B cells were sorted from 8-wk-old mice. 6 x 105 sorted effector T cells were cultured with 2 x 105 B cells in 600 mul of complete Click's media in a 48-well plate. Some wells were precoated with 20 mug/ml anti-CD3, and 1 mug/ml anti-CD28 was added in suspension. As a control, cells were stimulated with 10 mug/ml anti-CD40 with or without 50 ng/ml IL-4. Secreted IgG was measured in the culture supernatant after 96 h. IL-21 blocking antibody or isotype control (R&D Systems) were added at fivefold increments up to 50 mug/ml. CD40L blocking antibody (clone MR1; BD) was added at 200 ng/ml.
###end p 66
###begin title 67
Immunofluorescence microscopy.
###end title 67
###begin p 68
###xml 774 775 770 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 963 965 959 961 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 970 971 966 967 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 156 159 <span type="species:ncbi:10116">rat</span>
###xml 170 176 <span type="species:ncbi:9986">rabbit</span>
Spleens were snap frozen in optimal cutting temperature, cut into 6-muM sections, and fixed with ice-cold acetone. Rehydrated sections were blocked with 5% rat serum, 5% rabbit serum, and 3% BSA with 0.1% Tween, and stained with antibodies, including B220 (RA3-6B2; BD), IgM (R6-602; BD), IgM-AF647 (gift of M. Shlomchik), PSGL-1 (4RA10 or KPL-1; BD), TCRbeta (H57-597; eBioscience), F4/80 (BM8; eBioscience), and CD4 (RM4-5; eBioscience). Secondary detection was performed with anti-FITC-AF488 (Invitrogen), streptavidin-Cy3 (Jackson ImmunoResearch Laboratories), or streptavidin-AF647 (Invitrogen). Images were collected on a laser-scanning confocal microscope (model 510 META; Carl Zeiss, Inc.). Individual channels were uploaded into ImageJ software (available at ). CD4+ single cells were scored for their expression of PSGL-1 using the "ColocalizeRGB" and "Cell counter" plugins (default settings). Extrafollicular foci were defined as dense clusters of IgMhi B220- plasmablasts near the border of T cell zones. The red pulp was defined as the remaining area outside T cell zones, B cell follicles, and extrafollicular foci, and was confirmed on separate sections to display expression for F4/80.
###end p 68
###begin title 69
Statistical analysis.
###end title 69
###begin p 70
###xml 153 154 153 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
All data analysis was performed using Prism 4.0a (GraphPad Software, Inc.). In most cases, two-tailed p-values were calculated by the unpaired Student's t test. For populations that were unlikely to approximate a Gaussian distribution, two-tailed p-values were calculated using the Mann-Whitney test.
###end p 70
###begin title 71
Online supplemental material.
###end title 71
###begin p 72
###xml 110 114 <span type="species:ncbi:10090">mice</span>
Table S1 shows the genotypes of microsatellite markers within autoimmune susceptibility loci of a sampling of mice used in the study. Online supplemental material is available at .
###end p 72
###begin title 73
Supplementary Material
###end title 73
###begin title 74
[Supplemental Material Index]
###end title 74
###begin p 75
###xml 191 196 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aicda</italic>
###xml 268 283 <span type="species:ncbi:10090">transgenic mice</span>
We thank A. Rudensky for supporting J.M. Odegard during the revision of this manuscript. We are grateful to M. Shlomchik for providing the anti-IgM antibody, V. Odegard and D. Schatz for the aicda probe and PCR conditions, R. Mounzer and N. Ruddle for RIP-LTalphabeta transgenic mice, Anne Davidson for spleens of NZB/W F1 animals, and S. Kaech and A. Rudensky for their thoughtful comments.
###end p 75
###begin p 76
This work was supported by National Institutes of Health Grants AR40072 and AR44076, and by generous support from Rheuminations, Inc., the Arthritis Foundation, and the Connecticut Chapter of the Lupus Foundation of America.
###end p 76
###begin p 77
The authors declare that they have no financial conflicts of interest.
###end p 77

